| Authors: |
Emmerich CH; PAASP GmbH, Heidelberg, Germany. christoph.emmerich@paasp.net., Gamboa LM; Department of Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; QUEST Center for Transforming Biomedical Research, Berlin Institute of Health, Berlin, Germany., Hofmann MCJ; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Branch for Translational Medicine & Pharmacology TMP, Frankfurt am Main, Germany., Bonin-Andresen M; Department of Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Arbach O; Department of Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; SPARK-Validation Fund, Berlin Institute of Health, Berlin, Germany., Schendel P; Department of Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Gerlach B; PAASP GmbH, Heidelberg, Germany., Hempel K; Boehringer-Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Bespalov A; PAASP GmbH, Heidelberg, Germany.; Valdman Institute of Pharmacology, Pavlov Medical University, St. Petersburg, Russia., Dirnagl U; Department of Experimental Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.; QUEST Center for Transforming Biomedical Research, Berlin Institute of Health, Berlin, Germany., Parnham MJ; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Branch for Translational Medicine & Pharmacology TMP, Frankfurt am Main, Germany.; Faculty of Biochemistry, Chemistry & Pharmacy, J.W. Goethe University Frankfurt, Frankfurt am Main, Germany. |
